N. Fuente

752 total citations
22 papers, 74 citations indexed

About

N. Fuente is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Surgery. According to data from OpenAlex, N. Fuente has authored 22 papers receiving a total of 74 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 12 papers in Oncology and 3 papers in Surgery. Recurrent topics in N. Fuente's work include Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (6 papers). N. Fuente is often cited by papers focused on Lung Cancer Treatments and Mutations (7 papers), Colorectal Cancer Treatments and Studies (6 papers) and Cancer Treatment and Pharmacology (6 papers). N. Fuente collaborates with scholars based in Spain, Brazil and United States. N. Fuente's co-authors include Guillermo López-Vivanco, Alberto Múñoz, Aitziber Buqué, Ricardo Fernández, Begoña Calvo, Maria T. Perez, Ramón Barceló, Ram Thapa, Javier Martínez‐Trufero and Christine M. Pierce and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and PLoS ONE.

In The Last Decade

N. Fuente

18 papers receiving 72 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
N. Fuente Spain 5 50 39 15 12 9 22 74
Sophia J. Luo United States 5 43 0.9× 66 1.7× 10 0.7× 10 0.8× 7 0.8× 10 94
Béla Pikó Hungary 5 59 1.2× 19 0.5× 17 1.1× 22 1.8× 9 1.0× 20 89
Sabela Recalde Spain 5 41 0.8× 22 0.6× 9 0.6× 12 1.0× 9 1.0× 14 58
Kenisha Allen United States 3 38 0.8× 17 0.4× 25 1.7× 8 0.7× 23 2.6× 6 59
Jaklin Gukasyan United States 4 88 1.8× 37 0.9× 8 0.5× 15 1.3× 5 0.6× 5 96
Tasha Lea United States 2 18 0.4× 26 0.7× 15 1.0× 17 1.4× 6 0.7× 2 47
Vijay Gunuganti United States 3 29 0.6× 38 1.0× 18 1.2× 16 1.3× 6 0.7× 5 50
Foysal Daian United States 4 61 1.2× 35 0.9× 13 0.9× 10 0.8× 27 3.0× 5 96
Ulrich Gerigk Germany 3 22 0.4× 35 0.9× 42 2.8× 15 1.3× 4 0.4× 6 58
Alain Gratet France 3 23 0.5× 16 0.4× 11 0.7× 9 0.8× 9 1.0× 7 43

Countries citing papers authored by N. Fuente

Since Specialization
Citations

This map shows the geographic impact of N. Fuente's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by N. Fuente with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites N. Fuente more than expected).

Fields of papers citing papers by N. Fuente

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by N. Fuente. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by N. Fuente. The network helps show where N. Fuente may publish in the future.

Co-authorship network of co-authors of N. Fuente

This figure shows the co-authorship network connecting the top 25 collaborators of N. Fuente. A scholar is included among the top collaborators of N. Fuente based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with N. Fuente. N. Fuente is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Bailey, Alexis, Christine M. Pierce, N. Fuente, et al.. (2024). Metagenomic characterization of the tracheobronchial microbiome in lung cancer. SHILAP Revista de lepidopterología. 3. 1457537–1457537. 2 indexed citations
2.
Fuente, N., et al.. (2024). Delayed and Long-Lasting Response to 177Lu-DOTATATE in a Head and Neck Paraganglioma: Case Report and Literature Review. SHILAP Revista de lepidopterología. 17(1). 1252–1257.
3.
Fuente, N., et al.. (2022). The influence of carrying BRCA pathogenic mutations in ovarian cancer and its platinum-sensitivity: 5-year experience of a tertiary center.. Journal of Clinical Oncology. 40(16_suppl). e17572–e17572. 1 indexed citations
4.
5.
López-Vivanco, Guillermo, et al.. (2011). Gemcitabine (G) fixed-dose-rate infusion (FDR) plus erlotinib (E) in patients with advanced pancreatic cancer (APC).. Journal of Clinical Oncology. 29(4_suppl). 304–304. 6 indexed citations
6.
Múñoz, Alberto, et al.. (2010). Fixed-Dose-Rate Gemcitabine Infusion in Patients with Advanced Pancreatic or Biliary Tree Adenocarcinoma. Tumori Journal. 96(3). 405–410. 5 indexed citations
7.
Fuente, N., et al.. (2008). Toxicity of bevacizumab (BV) in metastatic colorectal carcinoma (MCRC): Analysis in 173 consecutive patients. Journal of Clinical Oncology. 26(15_suppl). 15069–15069. 1 indexed citations
8.
Martínez‐Bueno, Alejandro, et al.. (2007). First-line docetaxel (Dx) and capecitabine (Cap) in advanced head and neck cancer. Journal of Clinical Oncology. 25(18_suppl). 16505–16505. 2 indexed citations
9.
Martínez‐Bueno, Alejandro, Guillermo López-Vivanco, N. Fuente, et al.. (2006). Elderly patients with advanced non-small cell lung cancer (nsclc). Results of chemotherapy and comparison with younger patients. Journal of Clinical Oncology. 24(18_suppl). 18505–18505. 2 indexed citations
10.
Perez, Maria T., et al.. (2006). Tratamiento del dolor en el paciente oncológico. Redalyc (Universidad Autónoma del Estado de México). 103(2). 72–77. 2 indexed citations
11.
Fuente, N., et al.. (2005). Biweekly Administration of Cisplatin/Gemcitabine in Advanced Nonsmall Cell Lung Cancer. American Journal of Clinical Oncology. 28(5). 501–507. 12 indexed citations
12.
13.
López-Vivanco, Guillermo, et al.. (2004). Combination of oxaliplatin and capecitabine (CAPOX) in first and second-line treatment for metastatic colorectal carcinoma (MCRC). Journal of Clinical Oncology. 22(14_suppl). 3701–3701. 3 indexed citations
14.
López-Vivanco, Guillermo, et al.. (2004). Combination of oxaliplatin and capecitabine (CAPOX) in first and second-line treatment for metastatic colorectal carcinoma (MCRC). Journal of Clinical Oncology. 22(14_suppl). 3701–3701. 3 indexed citations
15.
Fernández, Ricardo, et al.. (2004). Cisplatin and capecitabine as first-line therapy for advanced gastric or gastroesophageal junction adenocarcinoma. Journal of Clinical Oncology. 22(14_suppl). 4187–4187. 2 indexed citations
16.
López-Vivanco, Guillermo, et al.. (2003). A novel biweekly schedule with cisplatin and gemcitabine in advanced non-small cell lung cancer.. PubMed. 23(1). 9–16. 2 indexed citations
17.
Fuente, N., et al.. (2003). Aspectos psicológicos del paciente con cáncer. 100(1). 28–31. 1 indexed citations
18.
Múñoz, Alberto, et al.. (2002). Phase II Study of Docetaxel/Vinorelbine in Patients with non—small-Cell-Lung Cancer Previously Treated with Platinum-Based Chemotherapy. Clinical Lung Cancer. 4(3). 168–173. 5 indexed citations
19.
López-Vivanco, Guillermo, et al.. (2000). Indicación de la Hormonoterapia en el Cáncer de Mama. 97(4). 119–121.
20.
López-Vivanco, Guillermo, et al.. (1999). Preoperative treatment with cisplatin-gemcitabine in locally advanced nsclc: Survival, toxicity and salvage surgery. European Journal of Cancer. 35. S256–S256. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Sophia J. Luo Breakdown of academic impact, for papers by Béla Pikó Breakdown of academic impact, for papers by Sabela Recalde Breakdown of academic impact, for papers by Kenisha Allen Breakdown of academic impact, for papers by Jaklin Gukasyan Breakdown of academic impact, for papers by Tasha Lea Breakdown of academic impact, for papers by Vijay Gunuganti Breakdown of academic impact, for papers by Foysal Daian Breakdown of academic impact, for papers by Ulrich Gerigk Breakdown of academic impact, for papers by Alain Gratet
Rankless by CCL
2026